Enclosed herewith Financial Results for the Quarter and Year ended on 31st March, 2025.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 4.9 pts less than Nifty Microcap 250 and 5.0 pts less than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Daikaffil Chemicals reported revenue from operations of ₹749.75 lacs for FY25 versus no reported operating revenue in FY24, suggesting commencement of commercial operations during the year. Total income for FY25 stood at ₹796.60 lacs but the company posted a net loss of ₹158.93 lacs (slightly narrower than FY24's loss of ₹190.22 lacs), translating to a loss per share of ₹2.65. The Board also appointed M/s. GMJ & Associates as Secretarial Auditor for five years and SPSJ & Associates LLP as Internal Auditor for FY26. The statutory auditor Natvarlal Vepari & Co LLP issued an unmodified opinion, while the FY24 comparatives were audited by the predecessor firm M/s. NGST & Associates.
The company remains loss-making with negative operating cash flow of ₹629.93 lacs, largely driven by a sharp jump in trade receivables (₹606 lacs) and inventory buildup, which has drained cash reserves from ₹751.91 lacs to just ₹66 lacs. While the loss is narrowing and operations have clearly begun, shareholders should monitor liquidity and working capital closely given the weak cash position and ongoing losses.